Conjugation of Hydroxyethyl Starch to Desferrioxamine (DFO) Modulates the Dual Role of DFO in Yersinia enterocolitica Infection
The iron chelator desferrioxamine (DFO) B is widely used in the therapy of patients with iron overload. As a side effect, DFO may favor the occurrence of fulminant Yersinia infections. Previous work from our laboratory showed that this might be due to a dual role of DFO: growth promotion of the path...
Guardat en:
| Publicat a: | Clin Diagn Lab Immunol |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
2000
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC95894/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10799461/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/cdli.7.3.457-462.2000 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|